Business plan of Nanotarg: a technological platform aiming to treat pancreatic cancer

Garriga Ferrer, Martina

Business plan of Nanotarg: a technological platform aiming to treat pancreatic cancer

License

Citation

Garriga Ferrer, M. Business plan of Nanotarg: a technological platform aiming to treat pancreatic cancer. 2020. handle: http://hdl.handle.net/10230/46448

This citation was generated automatically.

Abstract

Pharmaceutical industry is one of the most relevant activities and plays a major role in economics and the provision of global health. It is known that the processes of developing new compounds and its entry to the market are very complex and require specific guidelines that can only be provided by business and regulatory analytics. Although the key players in such industry are big companies, drug development is becoming a cooperative effort encouraging technology transfer since many compounds have their discovery origins in academia and small innovative companies, such as spin-offs. In this thesis, a business plan of the nanotechnological platform Nanotarg is presented. This technology, whose origin arises from academic research in Universitat Pompeu Fabra, enables specific targeting to tumoral tissue in the pancreas and can potentially release the therapeutic gold standard to increase the survival rate of pancreatic cancer patients. The goal of this project is to provide clear strategy lines for those researchers aiming to start the path of entrepreneurship. These business strategies derive from the exhaustive analysis of different features that affect pharmaceutical business development, among others, opportunity and market analysis are performed, as well as the SWOT and PESTEL analysis and financial projections to ensure profits and revenues.